全球冠状病毒检测试剂市场 – 行业趋势和 2030 年预测

冠状病毒检测试剂市场分析及规模

SARS-CoV-2 采样是有效诊断活动性感染的重要步骤。疾病控制和预防中心 (CDC) 和其他几个医疗保健组织已经推出了有效标本采集和简化 COVID-19 样本采集解决方案的标准程序和指导，从而促进了市场的发展。此外，血清学检测用于人群监测、诊断和抗体识别。

Data Bridge Market Research 分析，冠状病毒检测试剂市场规模从 2022 年的 105.9 亿美元飙升至 2030 年的 464.9 亿美元，预计在 2023 年至 2030 年的预测期内复合年增长率为 20.3%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

冠状病毒检测试剂市场范围和细分

Market Definition

Coronavirus test kits are the sampling techniques used to detect the coronavirus. These are of varied types and are hugely used in hospitals and research institutes. These test kits detect the novel coronavirus that spreads by close contact with an infected individual and is mainly spread via respiratory droplets produced by coughing and sneezing.

Global Coronavirus Test Kits Market Dynamics

Drivers

• Technological Advancements Associated with COVID-19 Test Kits

Different manufacturers created several innovative rapid testing kits, which include cards, cups, and smart test kits. Saliva samples were used in painless, quick testing kits. Moreover, test kits with quicker findings were launched on the market. Rapid testing is favored over other COVID-19 testing kits due to these developments. For instance, Meril Diagnostics, an international medical firm with operations in India, manufactures the non-prescription CoviFind COVID-19 Rapid Antigen Self-Test, which is widely available and has received approval from the Indian Council of Medical Research (ICMR) for routine usage in India. Therefore, as a result, this factor drives market growth.

• Increasing Initiatives by Authorised Organizations  

There have been increasing developments by organizations that are leading the market growth. For instance, the FDA granted LabCorp an Emergency Use Authorization (EUA) for a combination home collection kit in 2021 that may detect COVID-19 and influenza A/B in children as young as 2. Those who match clinical standards, such as having symptoms caused by coming in contact with someone having COVID-19, or being requested to be diagnosed by a healthcare physician, will receive the kit free of charge. Thus, these types of initiatives are helping in boosting the growth of the market.

Opportunities

• Wide Availability Of Swabs In Numerous Configurations

The increasing availability of swabs in several configurations for advanced infection detection is one of the major factors boosting the market growth. For instance, researchers at the University of South Florida (USF) Health launched a 3D-printed nasal swab prototype for commercial usage in 2020. As of 25th November 2020, the organization has launched 100,000+ products, and hospitals globally have implemented their 3D files to launch tens of millions more swabs for use in a point-of-care setting. Thus, this factor enhances the growth size.

• Increasing Need for Test Kits In Hospitals

The need for coronavirus test kits has extended along with the spread of coronavirus. With the help of test kits, coronavirus identification has become more essential than ever to control the infection's spread and increase market expansion. As the kits are based on techniques that include real-time IgM ELISA tests, polymerase chain reactions, and microneutralization assays, samples are taken from the different areas for testing. Thus, this factor boosts the market growth.

Restraints/Challenges

• Inaccuracy Associated with Fast Testing

The time required for the result takes more than 24 hours, which is a bit longer and will act as a restraint. The increased number of false-positive and false-negative results is one of the primary drawbacks of fast testing. COVID-19 test kits contain findings that were both falsely positive and falsely negative. When verified with other COVID-19 testing, people with COVID-19 symptoms both tested negative and positive simultaneously. These incidents reduced the use of COVID-19 fast test kits. Thus, this factor restricts the market growth.

This coronavirus test kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the coronavirus test kits market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2020, Hememics Biotechnologies Inc., which is a research and development business with headquarters in the U.S., created cooperation with the Biomedical Research and Development Authority (BARDA) to establish a rapid antigen and antibody detection instrument that is Bluetooth-enabled.

Global Coronavirus Test Kits Market Scope

The coronavirus test kits market is segmented on the basis of test type, sample type and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

• Molecular Testing
• Serological Testing

Sample Type

• Swab Test
• Nasal Aspirate
• Tracheal Aspirate
• Blood Test
• Sputum Test

End User

• Hospitals
• Point of Care Testing
• Reference Laboratories
• Home Care

Coronavirus Test Kits Market Regional Analysis/Insights

The coronavirus test kits market is analyzed and market size insights and trends are provided by test type, sample type and end-user as referenced above.

冠状病毒检测试剂盒市场报告涵盖的国家包括北美的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区的亚太地区其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲其他地区、巴西、阿根廷和南美洲其他地区。

由于产品审批和上市速度更快，以及家用检测试剂盒的分销更方便，北美在冠状病毒检测试剂盒市场占据主导地位。此外，该地区的政府机构积极参与疾病管理，推动了市场增长。

亚太地区在全球冠状病毒检测试剂盒市场占有最大份额，因此预计将出现显著增长。2019 年中国首次爆发疫情是检测试剂盒市场需求增加的主要因素之一。疫情的加剧导致该地区对检测试剂盒的需求增加。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。   

医疗保健基础设施增长安装基础和新技术渗透

冠状病毒检测试剂盒市场还为您提供了每个国家/地区资本设备医疗保健支出增长、冠状病毒检测试剂盒市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对冠状病毒检测试剂盒市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。

竞争格局和冠状病毒检测试剂盒市场份额分析

冠状病毒检测试剂盒市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对冠状病毒检测试剂盒市场的关注有关。

冠状病毒检测试剂盒市场的一些主要参与者包括：

• QIAGEN（德国）
• F.Hoffmann-La Roche Ltd（瑞士）
• Seegene Inc (韩国)
• SolGent 有限公司 (韩国)
• Curetis（德国）
• KURBO INDUSTRIES LTD.（日本）
•  Devex（美国）
• 赛默飞世尔科技（美国）
• Mylab Discovery Solutions Pvt. Ltd (印度)
• 雅培（美国）
• 盖特生物科技股份有限公司 (中国)
• Biomaxima SA（波兰）
• CTK Biotech, Inc（美国）
• 疾病预防控制中心（美国）
• 华大基因（中国）
• Luminex 公司（美国）
• PerkinElmer Inc（美国）

SKU-56293